Humana Expands Science-Based Targets with New SBTi-Validated Target
New target aims to reduce emissions from investments and lending activities, aligning financial influence with operational impact
The following outlines Humana's Scope 3 asset class level target, emphasizing our commitment to sustainable investment practices and alignment with SBTi-validated goals.
Scope 3 asset class level target |
||
Asset class |
Method |
Target language |
Listed equity and
|
Portfolio Coverage |
|
This complements the company's existing targets covering the rest of its value chain, including a commitment to reduce absolute Scope 3 emissions from purchased goods and services, as well as upstream transportation and distribution, by 30% by 2032 from a 2022 base year. The newly approved target for Scope 3, Category 15 financed emissions refer to the indirect greenhouse gas emissions from investments and lending activities.
To achieve the financed emissions target, Humana has revised its investment policy to incorporate SBTi-aligned climate commitments. These proactive measures highlight Humana's commitment to fostering healthier environments for its members, patients, employees, and communities, and aligns its financial influence with its operational impact.
Humana’s Scope 1 and 2 targets, approved in 2023, remain unchanged and continue to align with limiting global temperature rise. The company’s science-based targets and 1.5°C trajectory are designed to spur innovation and efficiency demonstrating ongoing leadership in climate action within the healthcare and insurance sectors, boost investor confidence and position Humana to support a broader decarbonization effort across its value chain and financial ecosystem.
To learn more about Humana’s environmental, social and governance strategy efforts to invest in the health and sustainability of our environment, visit the Humana Impact Report.
About Science Based Targets initiative
The Science Based Targets initiative (SBTi) is a collaboration between
The SBTi defines and promotes best practice in science-based target setting and independently assesses companies’ targets.
About Humana
View source version on businesswire.com: https://www.businesswire.com/news/home/20250624933843/en/
FOR MORE INFORMATION, CONTACT:
snelson31@humana.com
Source: